251 related articles for article (PubMed ID: 23547098)
1. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin.
Curran MA; Geiger TL; Montalvo W; Kim M; Reiner SL; Al-Shamkhani A; Sun JC; Allison JP
J Exp Med; 2013 Apr; 210(4):743-55. PubMed ID: 23547098
[TBL] [Abstract][Full Text] [Related]
2. Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.
Curran MA; Kim M; Montalvo W; Al-Shamkhani A; Allison JP
PLoS One; 2011 Apr; 6(4):e19499. PubMed ID: 21559358
[TBL] [Abstract][Full Text] [Related]
3. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
Qui HZ; Hagymasi AT; Bandyopadhyay S; St Rose MC; Ramanarasimhaiah R; Ménoret A; Mittler RS; Gordon SM; Reiner SL; Vella AT; Adler AJ
J Immunol; 2011 Oct; 187(7):3555-64. PubMed ID: 21880986
[TBL] [Abstract][Full Text] [Related]
4. An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Mittal P; Abblett R; Ryan JM; Hagymasi AT; Agyekum-Yamoah A; Svedova J; Reiner SL; St Rose MC; Hanley MP; Vella AT; Adler AJ
J Immunol; 2018 Feb; 200(4):1513-1526. PubMed ID: 29305435
[TBL] [Abstract][Full Text] [Related]
5. Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
Chacon JA; Wu RC; Sukhumalchandra P; Molldrem JJ; Sarnaik A; Pilon-Thomas S; Weber J; Hwu P; Radvanyi L
PLoS One; 2013; 8(4):e60031. PubMed ID: 23560068
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.
Joseph AM; Srivastava R; Zabaleta J; Davila E
Cancer Immunol Res; 2016 Aug; 4(8):708-16. PubMed ID: 27267778
[TBL] [Abstract][Full Text] [Related]
7. Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
Hernandez-Chacon JA; Li Y; Wu RC; Bernatchez C; Wang Y; Weber JS; Hwu P; Radvanyi LG
J Immunother; 2011 Apr; 34(3):236-50. PubMed ID: 21389874
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.
Hirschhorn-Cymerman D; Budhu S; Kitano S; Liu C; Zhao F; Zhong H; Lesokhin AM; Avogadri-Connors F; Yuan J; Li Y; Houghton AN; Merghoub T; Wolchok JD
J Exp Med; 2012 Oct; 209(11):2113-26. PubMed ID: 23008334
[TBL] [Abstract][Full Text] [Related]
9. Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.
Kim YM; Kim HK; Kim HJ; Lee HW; Ju SA; Choi BK; Kwon BS; Kim BS; Kim JB; Lim YT; Yoon S
Exp Mol Med; 2009 Dec; 41(12):896-911. PubMed ID: 19745604
[TBL] [Abstract][Full Text] [Related]
10. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization.
Willoughby JE; Kerr JP; Rogel A; Taraban VY; Buchan SL; Johnson PW; Al-Shamkhani A
J Immunol; 2014 Jul; 193(1):244-51. PubMed ID: 24860188
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation.
Kim DH; Chang WS; Lee YS; Lee KA; Kim YK; Kwon BS; Kang CY
J Immunol; 2008 Feb; 180(4):2062-8. PubMed ID: 18250411
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.
Lee DY; Choi BK; Lee DG; Kim YH; Kim CH; Lee SJ; Kwon BS
PLoS One; 2013; 8(7):e69677. PubMed ID: 23874982
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
15. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.
Compte M; Harwood SL; Muñoz IG; Navarro R; Zonca M; Perez-Chacon G; Erce-Llamazares A; Merino N; Tapia-Galisteo A; Cuesta AM; Mikkelsen K; Caleiras E; Nuñez-Prado N; Aznar MA; Lykkemark S; Martínez-Torrecuadrada J; Melero I; Blanco FJ; Bernardino de la Serna J; Zapata JM; Sanz L; Alvarez-Vallina L
Nat Commun; 2018 Nov; 9(1):4809. PubMed ID: 30442944
[TBL] [Abstract][Full Text] [Related]
16. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
Zhao Y; Croft M
Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
[TBL] [Abstract][Full Text] [Related]
17. Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.
Bartkowiak T; Jaiswal AR; Ager CR; Chin R; Chen CH; Budhani P; Ai M; Reilley MJ; Sebastian MM; Hong DS; Curran MA
Clin Cancer Res; 2018 Mar; 24(5):1138-1151. PubMed ID: 29301830
[No Abstract] [Full Text] [Related]
18. Enhanced CD4 T cell responsiveness in the absence of 4-1BB.
Lee SW; Vella AT; Kwon BS; Croft M
J Immunol; 2005 Jun; 174(11):6803-8. PubMed ID: 15905521
[TBL] [Abstract][Full Text] [Related]
19. Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory.
Park JJ; Anand S; Zhao Y; Matsumura Y; Sakoda Y; Kuramasu A; Strome SE; Chen L; Tamada K
Cancer Immunol Immunother; 2012 Feb; 61(2):203-214. PubMed ID: 21877247
[TBL] [Abstract][Full Text] [Related]
20. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
Lee SJ; Rossi RJ; Lee SK; Croft M; Kwon BS; Mittler RS; Vella AT
J Immunol; 2007 Aug; 179(4):2203-14. PubMed ID: 17675480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
